Eline C. Steenwijk

Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity

Iris L. A. Bodewes, Shereen Al-Ali, Cornelia G van Helden-Meeuwsen et al. · Lara D. Veeken · 2018 · 120 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome

Naomi I. Maria, Eline C. Steenwijk, Arne IJpma et al. · Annals of the Rheumatic Diseases · 2016 · 81 citations

Life Sciences, Immunology, Pathology +17

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?

M. J. Wahadat, Iris L. A. Bodewes, Naomi I. Maria et al. · Arthritis Research & Therapy · 2018 · 77 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3‐Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon‐Positive Primary Sjögren's Syndrome

Naomi I. Maria, Cornelia G van Helden-Meeuwsen, Zana Brkić et al. · Arthritis & Rheumatology · 2016 · 59 citations · Full text

Life Sciences, Immunology, Pathology +17

Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study

Paul G. Kemps, Timo C. E. Zondag, Helga B. Arnardóttir et al. · Blood Advances · 2022 · 50 citations · Full text

Medicine, Genetics, Oncology +17